CoChat
Sign Up
Cited by 338Fatty Acid Research and HealthDiabetes Treatment and ManagementNutritional Studies and Diet

The DOI matches its Crossref record; 65 of the 70 references it cites were found in a registry or an index.

Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension,,

Open access
Woodman, Richard J, Mori, Trevor A, Burke, Valerie, Puddey, Ian B, Watts, Gerald F, Beilin, Lawrence J·2002·The American Journal of Clinical Nutrition
DOI 10.1093/ajcn/76.5.1007
Open this paper in CoChat — free account

Abstract

Background n-3 Fatty acids lower blood pressure, improve lipids, and benefit other cardiovascular disease risk factors. Effects on glycemia in patients with type 2 diabetes are uncertain.Objective We determined whether purified eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have differential effects on glycemic control, including insulin sensitivity and stimulated insulin secretion; 24-h ambulatory blood pressure; and serum lipids in type 2 diabetic patients with treated hypertension.Design In a double-blind, placebo-controlled trial of parallel design, 59 subjects were randomly assigned to consume 4 g EPA, DHA, or olive oil/d for 6 wk while continuing to consume their usual diet.Results Thirty-nine men and 12 postmenopausal women with a mean (+/- SE) age of 61.2 +/- 1.2 y completed the study. In comparison with the change from baseline in fasting glucose in the olive oil group, fasting glucose in the EPA and DHA groups increased 1.40 +/- 0.29 mmol/L (P = 0.002) and 0.98 +/- 0.29 mmol/L (P = 0.002), respectively. Neither EPA nor DHA had significant effects on glycated hemoglobin, fasting insulin or C-peptide, insulin sensitivity or secretion, or blood pressure. Serum triacylglycerols in the EPA and DHA groups decreased 19% (P = 0.022) and 15% (P = 0.022), respectively. There were no significant changes in serum total, LDL, or HDL cholesterol, although HDL(2) cholesterol in the EPA and DHA groups increased 16% (P = 0.026) and 12% (P = 0.05), respectively. HDL(3) cholesterol decreased 11% (P = 0.026) with EPA supplementation.Conclusions EPA and DHA had similar benefits on lipids but adverse effects on short-term glycemic control in hypertensive diabetic patients. The overall implications for cardiovascular disease require long-term evaluation.

Overview

Integrity signals

Registry

Crossref · 10.1093/ajcn/76.5.1007

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 70 references

5 of the 70 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Bonnema, 1995, Supplementation with olive oil rather than fish oil increases small arterial compliance in diabetic patients, Diabetes Nutr Metab, 8, 81
  2. Nozaki, 1992, Effects of purified eicisapentaenic acid ethy lester on plasma lipoprateins in primary hypercholesterolcmia, Int J Vitam Nutr res, 62, 256

Cited by

Sorted by citations

Items 301–338 of 338

Related

See all

Metadata

Authors
Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., & Beilin, L. J.
Affiliations
The University of Western Australia (AU)
ORCID
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2002-11
Volume
76
Issue
5
Pages
1007-1015
ISSN
0002-9165 (ISSN-L)
DOI
10.1093/ajcn/76.5.1007
OpenAlex
W2114249119
Cited by
338
References
70
Citations by year
2025: 6 · 2024: 8 · 2023: 9 · 2022: 7 · 2021: 10 · 2020: 10 · 2019: 12 · 2018: 12 · 2017: 21 · 2016: 10 · 2015: 16 · 2014: 20 · 2013: 28 · 2012: 20
FWCI
6.38
Type
journal article
Language
en
Open access
Licence
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
eicosapentaenoic acid, docosahexaenoic acid, omega-3 fatty acids, type 2 diabetes, hypertension, glycemic control, fasting blood glucose, insulin sensitivity, insulin secretion, blood pressure, serum lipids, HDL cholesterol, triglycerides, olive oil
MeSH terms
Olive Oil, Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 2, Docosahexaenoic Acids, Double-Blind Method, Fatty Acids, Female, Heart Rate, Humans, Hypertension, Insulin, Lipids, Lipoproteins, Male, Middle Aged, Phospholipids, Plant Oils, Eicosapentaenoic Acid, Blood Pressure Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review